FDA Gives OK to First New Flu Drug in 20 Years
Dec 04, 2018
For the first time in two decades, the U.S. Food and Drug Administration has approved a new type of antiviral flu drug.
The single oral dose of Xofluza (baloxavir marboxil) is for the treatment of uncomplicated flu in patients aged 12 and older who have had symptoms for no more than 48 hours.
Share It :- twiter
- Google Plus
